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The metabolism of the double bonds at the A3 position in fatty acids was studied in rat liver. Infusion of 
A3-trans-dodecenoic a id into isolated perfused liver and subcellular fractionation studies showed the pres- 
ence of both peroxisomal and mitochondrial A3,A2-enoyl-CoA isomerase activity (EC 5.3.3.8). These find- 
ings together with the previous demonstration of peroxisomal 2,Cdienoyl-CoA reductase (EC 1.3.1.34) 
[(1981) J. Biol. Chem. 256, 8259-82621 and D-3-OH-acyl-CoA epimerase (EC 5.1.2.3) [(1985) FEBS Lett. 
185, 129-1341 activities show that peroxisomes possess all the auxiliary enzymes required for the 8-oxidation 
of unsaturated fatty acids. 
Polyunsaturated fatty acid; Peroxisome; Catalase compound I; Organ spectroscopy; (Rat liver) 
1. INTRODUCTION 
Very-long-chain fatty acids accumulate in pa- 
tients with deficient peroxisomal &oxidation as a 
consequence of an inherited disease [l-4]. This 
fact together with the in vitro characteristics of 
peroxisomal P-oxidation indicates that the 
physiological task of this metabolic process is the 
catabolism of long-chain fatty acids [5]. Long- 
chain fatty acids in nature are often unsaturated, 
however, and are usually degraded only slowly in 
mitochondria. Many polyunsaturated fatty acids 
(PUFA) are even inhibitors of mitochondrial fi- 
oxidation [6]. 
The first indication that peroxisomes may be 
specifically involved in the metabolism of PUFA 
emerged from the demonstration of the existence 
of peroxisomal 2,Cdienoyl-CoA reductase in rat 
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liver [7]. Similarly, 3-OH-acyl-CoA epimerase ap- 
pears to be a peroxisomal enzyme [8]. 
The third auxiliary enzyme involved in the & 
oxidation of unsaturated fatty acids is A3,A2-enoyl- 
CoA isomerase, which catalyzes the isomerization 
of the double bond in position 3 of acyl-CoA 
derivatives to position 2. As a step towards the 
understanding of the role of peroxisomes in the 
catabolism of unsaturated fatty acids, it is 
necessary to know whether they can metabolize 
double bonds at odd-numbered positions in fatty 
acids. This prompted us to study the subcellular 
distribution of this isomerase activity in the liver. 
2. MATERIALS AND METHODS 
The fatty acids used were all commercially 
available, except for A3-trans-dodecenoic acid, 
which was synthesized by condensing decyl 
aldehyde with malonic acid in the presence of 
triethanolamine [9]. The acyl-CoA esters were syn- 
thesized by the mixed anhydride method [lo] and 
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purified on cellulose thin-layer plates [l 11. The 
concentration of acyl-CoA esters was determined 
as described by Ellman [12] after cleaving the 
thioester bond with hydroxylamine at pH 7.0. 
Male Sprague-Dawley rats were fed with a com- 
mercial pelleted diet supplemented with 0.3% 
(w/w) clofibrate for 12-14 days prior to ex- 
periments. Isolated livers were perfused with 
Krebs-Henseleit bicarbonate solution in equilibri- 
um with OJCOz (19: 1) without recirculation. 
Substrates were added by micropump-controlled 
infusion of stock solutions, the short-chain fatty 
acids in the form of sodium salts and the medium- 
chain-length acids in bovine serum albumin com- 
plexes. Organ spectrophotometry and surface 
fluorometry of the liver were performed 
simultaneously, as described in 1131. 
10% (w/v) liver homogenates were prepared in 
0.25 M sucrose/O.l% (v/v) ethanol12 mM 3-W 
morpholino)propanesulphonic acid (pH 7.2)/l 
mM EGTA in a Potter-Elvehjem type 
homogenizer with a loosely fitting Teflon pestle. 
The homogenate was centrifuged at 800 x g for 
10 min to separate out the nuclei (N). The heavy 
mitochondrial fraction (H) was obtained by cen- 
trifugation of the supernatant at 5100 x g for 
10 min and the light mitochondrial fraction (L) 
was the pellet from an additional centrifugation at 
27000 x g for 10 min. The supernatant was cen- 
trifuged at 100000 x g for 1 h to yield the 
microsomal fraction (M) as a pellet and soluble 
proteins as the supernatant (S) [14]. To separate 
the subcellular organelles further, a portion of the 
L-fraction from the clofibrate-fed rats was loaded 
onto a discontinuous sucrose gradient and cen- 
trifuged in a Sorval RC-2B centrifuge with an 
SS-90 vertical rotor at 40600 x g for 50 min as in 
t71. 
Catalase [ 151, glucose-6-phosphatase [ 161, 
glutamate dehydrogenase [17] and acid phospha- 
tase [18] were measured as described. A3,A2-Enoyl- 
CoA isomerase was measured with 80pM 
A3-trans-dodecenoyl-CoA in the presence of 8 pM 
rotenone [19]. Proteins were measured with the 
BioradR protein assay reagent using bovine serum 
albumin as a standard. 
3. RESULTS 
Infusion of laurate into an isolated perfused 
liver resulted in an increase in the level of the 
catalase-Hz02 complex (compound I), indicating 
an increase in Hz02 production. Since peroxisomal 
acyl-CoA oxidase is an Hz02 producer, compound 
I also serves as a probe for the subcellular location 
of partial reactions of fatty acid oxidation [20,21]. 
Laurate infusion also resulted in some quenching 
of flavoprotein fluorescence, and since the latter 
has been shown in the liver to be mainly due to 
mitochondrial lipoamide dehydrogenase [22], 
which is in equilibrium with the mitochondrial free 
NADH/NAD+ pool, the result indicates that 
mitochondria are also involved in the metabolism 
of laurate. The increment in the level of compound 
I during 3-trans-dodecenoate infusion suggests the 
presence of A3,A2-enoyl-CoA isomerase in perox- 
isomes, as isomerization of the double bond and 
chain shortening by one acetyl unit are required 
before Hz02 generation. The short-chain fatty 
acids tested here were all metabolised in mitochon- 
dria, as indicated by the quenching of flavoprotein 
fluorescence, but only hexanoate caused a small in- 
crease in the compound I concentration. The 
response pattern of the compound I level and 
flavoprotein fluorescence to ethanol, methanol 
and glycolate corroborates the proper functioning 
of the compartment-specific metabolic probes used 
(fig.1). 
The enzyme activities measured in the liver 
homogenates are given in table 1. In order to study 
the subcellular localization of isomerase, the liver 
homogenates from the clofibrate-treated rats were 
fractionated by differential centrifugation. A 
graphic presentation of the results is given in fig.2. 
Recovery of enzyme activity in the fractions varied 
in the range 60-118% in different preparations. 
The distribution of isomerase resembled most that 
of glutamate dehydrogenase, suggesting a 
mitochondrial location for the bulk of the 
isomerase. The results of differential centrifuga- 
tion of livers from control rats gave a similar 
distribution (not shown). 
Further isopycnic centrifugation of the L- 
fraction on a sucrose gradient revealed a dual 
distribution of A3,A2-enoyl-CoA isomerase activity 
(fig.3), the isomerase peak at a density of 45-50070 
sucrose coinciding with the maximum for catalase, 
a marker enzyme for peroxisomes, and the second, 
at a density of 38-4290 sucrose, with glutamate 
dehydrogenase. Although the maximum for acid 
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Fig. 1. Catalase compound I, flavoprotein fluorescence and oxygen consumption during infusion of isolated rat liver 
with selected fatty acids. The perfusion rate was 4.8 ml/min per g wet wt tissue. Ethanol (EtOH) (25 mM) and methanol 
(0.08 mM) were present in the perfusion medium where indicated. The Cg and Cl2 fatty acids were infused at final 
concentrations of 0.71 and 0.08 mM, respectively. The glycolate (glyc) concentration was 1 .O mM. 6: 0, hexanoic acid; 
trans 6 : 1, A3-trans-hexenoic acid; cis 6 : 1, A3-cis-hexenoic acid; 12 : 0, lauric acid; trans 12 : 1, A3-trarrs-dodecenoic a id. 
phosphatase, a marker enzyme for lysosomes, was 
located in the same fraction, the data in fig.2 do 
not support the existence of lysosomal isomerase 
activity. 
4. DISCUSSION 
The major finding to emerge here is the direct 
demonstration of peroxisomal A’,A2-enoyl-CoA 
isomerase activity, while the stimulation of Hz02 
generation by 3-trans-dodecenoate infusion in 
isolated liver showed that this enzyme is also active 
in situ. 
2,4-Dienoyl-CoA reductase is essential for the& 
oxidation of fatty acids having double bonds at 
even-numbered carbon atoms, counted from the 
carboxy end of the molecule, in both mitochondria 
and peroxisomes [7,13,23-251. This fact and the 
present demonstration of peroxisomal isomerase 
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Table 1 
Activities of A3,A2-enoyl-CoA isomerase and marker 
enzymes of subcellular organelles in livers from normal 
and clofibrate-fed rats 
Component Control Clofibrate 
Liver weight/body 
weight (10m3 w/w) 49 f 2 (5) 70 j, 15b (6) 
Protein (mg/g liver) 199 f 24 (6) 195 f 32 (5) 
Catalase 668 + 81 (6) 814 + 171= (6) 
Glutamate dehydro- 
genase 452 f 73 (6) 509 ? 97 (6) 
A3,A2-Enoyl-CoA 
isomerase 302 f 140 (5) 592 + 10lb (4) 
Glucose-6-phosphatase 140 f 29 (6) 145 + 42 (5) 
Acid phosphatase 45 Z!Z 8 (6) 43 + 7 (5) 
a P < 0.05, b P < 0.01 (clofibrate-fed rats vs controls) 
Values are means f SD from the numbers of 
experiments in parentheses. Enzyme activities are given 
in mU/mg protein 
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Fig.2. Separation of subcellular organelles from livers 
from clofibrate-fed rats by differential centrifugation. 
(A) Catalase, (B) glutamate dehydrogenase, (C) 
isomerase, (D) glucose&phosphatase and (E) acid 
phosphatase. (N) Nuclei, (H) heavy mitochondria, (L) 
light mitochondria, (M) microsomes, (S) soluble 
proteins. Results shown are means from 4-6 individual 
fractionation experiments. 
activity together indicate that peroxisomes possess 
enzymes which are obligatory for the metabolism 
of double bonds in both even- and odd-numbered 
positions. Consequently, peroxisomal &oxidation 
of unsaturated fatty acids should be able to pass 
the pre-existing double bonds. These findings are 
in line with one of the general physiological roles 
proposed for peroxisomal p-oxidation, namely 
prevention of the accumulation of fatty acids 
which are degraded only slowly in other metabolic 
pathways [5,6]. This conclusion is supported fur- 
ther by recent findings that many PUFA (ex- 
cluding arachidonic acid) can undergo rapid 
peroxisomal B-oxidation in isolated peroxisomes, 
isolated liver cells and in isolated perfused rat 
livers [13,26]. 
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Fig.3. Subcellular localization of A3,A2-enoyl-CoA 
isomerase rat liver as revealed by centrifugation of the L- 
fraction of liver homogenate in a discontinuous sucrose 
gradient. The upper lines in the panels give the sucrose 
concentrations and the lower ones the distribution of 
protein (A), glucose-6-phosphatase (B), isomerase (C), 
acid phosphatase (D), glutamate dehydrogenase (E) and 
catalase (F). The frequency stands for (value of 
parameter in fraction) x (sum for parameter in all 
fractions)-’ x 100. 
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